Genocea Biosciences Analysis
| GNCADelisted Stock | USD 0.0002 0.0001 100.00% |
Genocea Biosciences is overvalued with Real Value of 1.9E-4 and Hype Value of 2.5E-4. The main objective of Genocea Biosciences delisted stock analysis is to determine its intrinsic value, which is an estimate of what Genocea Biosciences is worth, separate from its market price. There are two main types of Genocea Biosciences' stock analysis: fundamental analysis and technical analysis.
The Genocea Biosciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Genocea Biosciences' ongoing operational relationships across important fundamental and technical indicators.
Genocea |
Genocea Stock Analysis Notes
The company has price-to-book (P/B) ratio of 0.01. Some equities with similar Price to Book (P/B) outperform the market in the long run. Genocea Biosciences recorded a loss per share of 0.53. The entity last dividend was issued on the 22nd of May 2019. The firm had 1:8 split on the 22nd of May 2019. Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Genocea Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 74 people. To learn more about Genocea Biosciences call William MBA at 617 876 8191 or check out https://www.genocea.com.Genocea Biosciences Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Genocea Biosciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Genocea Biosciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Genocea Biosciences is not yet fully synchronised with the market data | |
| Genocea Biosciences has some characteristics of a very speculative penny stock | |
| Genocea Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.64 M. Net Loss for the year was (33.2 M) with profit before overhead, payroll, taxes, and interest of 1.64 M. | |
| Genocea Biosciences currently holds about 20.14 M in cash with (45.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Genocea Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.88 K.Genocea Biosciences Outstanding Bonds
Genocea Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Genocea Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Genocea bonds can be classified according to their maturity, which is the date when Genocea Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| Genworth Financial 65 Corp BondUS37247DAB29 | View |
Genocea Biosciences Predictive Daily Indicators
Genocea Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Genocea Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Genocea Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Genocea Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Genocea shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Genocea Biosciences. By using and applying Genocea Stock analysis, traders can create a robust methodology for identifying Genocea entry and exit points for their positions.
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Genocea Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 74 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Genocea Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Genocea Stock
If you are still planning to invest in Genocea Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genocea Biosciences' history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |